Ventech China is a venture capital firm based in Shanghai, specializing in early-stage investments across diverse sectors, including B2B, B2C, software, and hardware. As a part of the larger Ventech network established in France in 1998, it manages multiple funds focused on the Asian market. Ventech China's investment strategy encompasses a range of industries, with particular emphasis on communities, M-commerce, Big Data, and Fintech. Its portfolio includes notable companies such as Keep, a leading fitness training app, WonderFull, a Japanese M-commerce platform, Juzi, a prominent entertainment news platform, Datawin, a key player in big data solutions for sales leads, and Blued, a leading gay community app in China. Ventech China aims to support innovative startups on their journey to becoming global leaders in their respective fields.
Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.
Prewave
Series A in 2023
Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.
Prewave
Series A in 2022
Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.
Prewave
Seed Round in 2020
Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.
Themis Bioscience
Series D in 2019
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
Themis Bioscience
Series C in 2018
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
Themis Bioscience
Series B in 2016
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
Asgoodasnew
Series C in 2015
Asgoodasnew electronics GmbH is a leading provider of refurbished consumer electronics in Europe. The company operates an online retail platform that offers a wide range of gadgets, including cellphones, music players, portable navigation systems, computers, smart accessories, and gaming devices. Through its trade-in services, such as WIRKAUFENS in Germany and Austria, LOCOMPRAMOS in Spain, and KUPIMYTO in Poland, Asgoodasnew allows customers to easily and securely convert their used electronics into cash. By selling refurbished products both directly to consumers and businesses, Asgoodasnew aims to provide affordable alternatives to new devices while maintaining the quality and reliability that consumers expect.
Asgoodasnew
Series B in 2012
Asgoodasnew electronics GmbH is a leading provider of refurbished consumer electronics in Europe. The company operates an online retail platform that offers a wide range of gadgets, including cellphones, music players, portable navigation systems, computers, smart accessories, and gaming devices. Through its trade-in services, such as WIRKAUFENS in Germany and Austria, LOCOMPRAMOS in Spain, and KUPIMYTO in Poland, Asgoodasnew allows customers to easily and securely convert their used electronics into cash. By selling refurbished products both directly to consumers and businesses, Asgoodasnew aims to provide affordable alternatives to new devices while maintaining the quality and reliability that consumers expect.
Themis Bioscience
Series A in 2011
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
Asgoodasnew
Series A in 2011
Asgoodasnew electronics GmbH is a leading provider of refurbished consumer electronics in Europe. The company operates an online retail platform that offers a wide range of gadgets, including cellphones, music players, portable navigation systems, computers, smart accessories, and gaming devices. Through its trade-in services, such as WIRKAUFENS in Germany and Austria, LOCOMPRAMOS in Spain, and KUPIMYTO in Poland, Asgoodasnew allows customers to easily and securely convert their used electronics into cash. By selling refurbished products both directly to consumers and businesses, Asgoodasnew aims to provide affordable alternatives to new devices while maintaining the quality and reliability that consumers expect.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.